Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Monsanto Co. -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (1340)	2/24/1999 12:27:00 AM
From: John R. Sashko	Read Replies (1) \| Respond to of 2539

Anthony, Great article. It isn't more expensive. You know I had to complete 2 forms to switch a patient from Relafen to Celebrex. What bothers me is that the insurance company was actually saving money with the switch! Crazy world... I believe the so called experts are too worried about labeling. Most physicians are intelligent and will use a medication for off-label use as long as they believe it will benefit the patient. Convincing health plans to add Celebrex to their formulary should be the priority here.

To: Anthony Wong who wrote (1340)	2/24/1999 1:35:00 AM
From: Dan Spillane	Read Replies (1) \| Respond to of 2539

Picture BBC headline: Tory party misled by 'bad science', Greenpeace has 'no comment' 1) My understanding is the new story from the respected scientists appeared first in the more conservative (Tory) papers; up until a few days ago, the Tory party had been the ones babbling abut the older report related to the fired scientist! Do I smell a second scandal to follow the first scandal? 2) Also, BBC online used to have a link to another "bad science" story on their web page -- for one of the Greenpeace associated groups -- but now I can't find it. This is fascinating to watch. Better than the Clinton scandal...except clearly Greenpeace is guilty! They did it...their seed is in Tony Blair's front yard!